Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.
Banda M, Speyer CL, Semma SN, Osuala KO, Kounalakis N, Torres Torres KE, Barnard NJ, Kim HJ, Sloane BF, Miller FR, Goydos JS, Gorski DH.
Banda M, et al. Among authors: miller fr.
PLoS One. 2014 Jan 3;9(1):e81126. doi: 10.1371/journal.pone.0081126. eCollection 2014.
PLoS One. 2014.
PMID: 24404125
Free PMC article.